Inflammasomes as biomarkers and therapeutic targets in traumatic brain injury and related-neurodegenerative diseases: A comprehensive overview

Dania Kattan, Chloe Barsa, Sarin Mekhijian, Zaynab Shakkour, Maya Jammoul, Mark Doumit, Maria Camila Pareja Zabala, Nadine Darwiche, Ali H. Eid, Yehia Mechref, Kevin K. Wang, Juan Pablo de Rivero Vaccari, Jennifer C. Munoz Pareja, Firas Kobeissy

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Abstract

Given the ambiguity surrounding traumatic brain injury (TBI) pathophysiology and the lack of any Food and Drug Administration (FDA)-approved neurotherapeutic drugs, there is an increasing need to better understand the mechanisms of TBI. Recently, the roles of inflammasomes have been highlighted as both potential therapeutic targets and diagnostic markers in different neurodegenerative disorders. Indeed, inflammasome activation plays a pivotal function in the central nervous system (CNS) response to many neurological conditions, as well as to several neurodegenerative disorders, specifically, TBI. This comprehensive review summarizes and critically discusses the mechanisms that govern the activation and assembly of inflammasome complexes and the major methods used to study inflammasome activation in TBI and its implication for other neurodegenerative disorders. Also, we will review how inflammasome activation is critical in CNS homeostasis and pathogenesis, and how it can impact chronic TBI sequalae and increase the risk of developing neurodegenerative diseases. Additionally, we discuss the recent updates on inflammasome-related biomarkers and the potential to utilize inflammasomes as putative therapeutic targets that hold the potential to better diagnose and treat subjects with TBI.

Original languageEnglish
Article number104969
JournalNeuroscience and Biobehavioral Reviews
Volume144
DOIs
StatePublished - Jan 2023

Keywords

  • Biomarkers
  • Caspase-1
  • Inflammasomes
  • NLPR1
  • Neurodegenerative diseases
  • Pyroptosis
  • Therapeutic targets
  • Traumatic brain injury

Fingerprint

Dive into the research topics of 'Inflammasomes as biomarkers and therapeutic targets in traumatic brain injury and related-neurodegenerative diseases: A comprehensive overview'. Together they form a unique fingerprint.

Cite this